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Abstract: 
Recently it has been demonstrated that mixtures of oppositely charged surfactants or 
lipids, known as catanionic mixtures, present a wide variety of organized assemblies and 
aggregates with improved physicochemical properties compared to those of the individual 
components.. Isotherms of lichenysin-C3(LA)2 indicate a strong interaction suggesting 
the formation of a new “pseudo-surfactant”. The antimicrobial properties of the mixture 
lichenysin and C3(LA) M80:20, indicate a synergistic effect of the components. The 
mechanism of action on the bacterial envelope was assessed by flow cytometry and 




The continuous emergence of bacterial strains resistant to conventional preservatives 
has become a major problem in recent years [1, 2] and has prompted a search for 
alternative preservative systems. In the search for new antimicrobial agents able to reduce 
resistance and toxicity with wider activity spectra, a current trend is to explore mixtures 
of already existing antimicrobial agents [3-6]. 
Recently it has been demonstrated that mixtures of oppositely charged surfactants or 
lipids, known as catanionic mixtures, present a wide variety of organized assemblies and 
aggregates with improved physicochemical and antimicrobial properties compared to 
those of the individual components, attributed to synergistic effects [7,8]. These results 
prompted us to explore mixtures of lichenysin, an anionic biosurfactant, and Nα,Nω-
bis(Nα-lauroyl-lysine) α,ω-hexylendiamide (C6(LL)2) and N
α,Nω-bis(Nα-lauroyl α,ω-
propylendiamide (C3(LA)2, two amino acid-based gemini cationic surfactants (Fig. 1). 
Lichenysin (LchAL·1.1) is a cyclic lipopeptide produced by Bacillus licheniformis similarly 
to surfactin, with a highly surface tension activity in water (29 mN/m) with a very low 
(15mg/L) critical micelle concentration (CMC) [9,10], however lichenysin did not 
exhibited antimicrobial activity such that of surfactin [11]. Arginine- or lysine-based 
gemini surfactants (Fig. 1) are highly effective in reducing surface tension (30 mN/m for 
C6(LL)2 and 35 mN/m for C3(LA)2), have very low CMC (~ 5 x 10
-3 mM) and show 
antimicrobial activity with moderate toxicity [12-14]. Because of their high surface and 
antimicrobial activities, several potential biomedical therapeutic and prophylactic 
applications have been described for these compounds, which have drawn the attention 
of cosmetic, biomedical and pharmaceutical industries [8-13].  
To assess the biological properties of the surfactant binary systems described, we 
conducted an in vitro evaluation of the antimicrobial activity of LchAL·1.1 and two gemini 
compounds, C6(LL)2) or C3(LA)2, alone and as mixtures, against the pathogenic strains 
Escherichia coli O157:H7 and Listeria monocytogenes, both considered a challenge to 
food security. The effect of the gemini arginine /lichenysin catanionic surfactant mixture 
on cell viability and on functional and structural cell integrity was investigated.  
 
Material and methods  
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2.1 Synthesis and production of surface active molecules 
The gemini surfactants C6(LL)2 and C3(LA)2 were synthesized and purified as reported 
[15-17]. Lichenysin (LchAL1.1), was obtained as previously described [18] . The structures 
of all compounds are shown in Fig. 1.   
2.2 Physicochemical characterization of surface active molecules 
2.2.1 π-A Compression Isotherms 
To obtain surface pressure versus mean molecular area (π-A) isotherms at room 
temperature, a computer-controlled Langmuir balance (KSV Instruments Ltd. Helsinki) 
364 mm long and 75 mm wide was used. The surface pressure was measured with a 
Wilhelmy plate made of filter paper (Whatman ashless, 70 mm Ø). The uncertainty of the 
Langmuir balance is ±0.1 mN/m. Before spreading, the surface was compressed and the 
top layer of the subphase aspirated with a Pasteur pipette. The surface was considered 
clean after checking that the pressure rise between full expansion and full compression 
was <0.1 mN/m. Samples were prepared by weight at a concentration of 1 mg/mL in 
chloroform for C3(LA)2 and C3(LA)2/ LchAL1.1  and in hexane/methanol (9:1) solvent for 
C6(LL)2 and C6(LL)2/LchAL1.1. Sample aliquots of 20 μL were spread onto the surface of 
buffer solutions of TRIS (pH 7.4). After solvent evaporation, symmetric compression of 
the monolayer was done at 20 mm2/min rate. The reproducibility of the surface pressure 
was higher than 0.4 mN/m [19]. 
2.2.2 Size and zeta potential  
LchAL1.1, C3(LA)2, and mixtures of C3(LA)2/LchAL1.1 (M80:20, M50:50) were prepared 
in concentrations of 2 mM in distilled water. The size and zeta potential of aggregates 
were obtained by analysing the samples in a Zetasizer Malvern Nano-ZS using a 
ZeNO112 cell. The value was taken as the mean of three independent measurements. 
Each measurement was in turn the average of ten sub-measurements of 20 s each [20].  
 
 
2.3 Biological activity  
2.3.1 Antimicrobial activity 
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The antimicrobial activity was determined on the basis of the minimum inhibitory 
concentration (MIC) [21]. Gemini surfactants and the binary systems were dissolved in 
Muller Hinton Broth (MHB, Oxoid, Basingstoke, UK,) in the concentration range of 
0.1−256 μg/mL (0.1-250 µM). LchAL1.1 concentrations between 0.2-1024 μg/mL (0.2-1 
mM) were assayed. An aliquot of 200 μL of each concentration was dispensed in the 
corresponding well of a 96-well polypropylene microtiter plate (Costar; Corning, NY, 
USA). Then, 10 μL of an overnight culture on MHB, of the corresponding microorganism 
were added to achieve a final concentration of 104-105 CFU/mL. Inoculated MHB served 
as a growth control. Microorganism growth was determined visually after 24 h incubation 
at 37 °C. For MIC determinations, Escherichia coli ATCC 25922, Escherichia coli 
O157:H7 CECT 4267, Pseudomonas aeruginosa ATCC 27853, Yersinia enterocolitica 
ATCC 9610, Klebsiella pneumoniae ATCC 13883, Staphylococcus aureus ATCC 29213, 
Kocuria rhizophila (previously Micrococcus luteus) ATCC 9341, Bacillus subtilis ATCC 
6633, Staphylococcus epidermis ATCC 12228, Listeria monocytogenes ATCC 15313, 
methycillin-resistant Staphylococcus aureus (MRSA) ATCC 43300 and Candida 
albicans ATCC 10231 were used. Strains were subcultured fortnightly on tryptone soy 
agar plates (TSA, Pronadisa, Barcelona, Spain) and were preserved frozen in cryovials 
(EAS laboratories, France) at -80 ºC.  
 To evaluate the potential synergism of both surfactants assayed, the fractional 
inhibitory concentration (FIC) was determined according to the equation: 
FIC= [(MICAM/MICA) + (MICBM/MICB)] 
Where MICAM is the MIC of the geminal in the mixture, MICA is the MIC of the pure 
geminal, MICBM is the MIC of the lipopeptide in the mixture, and CMIB is the MIC of the 
pure lipopeptide [22].  Differences between FIC data were analysed with the paired t-
student test according to Schwartz, D. [23]. 
 
 




Microorganisms, cultured for 24h at 30ºC in TSA were washed twice (8,000 x g, 20 
min; Allegra 25R, Beckman) in sterile Ringer solution (Scharlau, Barcelona, Spain). an 
aliquot of washed bacteria was added to peptone-buffered water (Oxoid, Basingstoke, 
UK) to obtain a cell density of about 107–108 CFU/mL. A volume of C3(LA)2/LchAL1.1 
(M80:20) stock solution (2 mM) was added to flasks to reach the MIC value for E. coli 
O157:H7 and L. monocytogenes (6.25 µM). Single components were added at a final 
concentration of 5 µM for C3(LA)2 and 1.25 µM for LchAL1.1. The inoculated flasks were 
kept in darkness at room temperature. 
2.3.3 Bacterial count  
After exposure, samples were diluted 1:10 with sterile Ringer solution for surfactant 
inactivation. Bacterial viability was calculated by viable cell counts, calculated from the 
colony forming units (CFU/mL). Briefly, after ten-fold serial dilution of treated bacterial 
suspension, 0.1 mL aliquots were spread on TSA plates surface and incubated at 37ºC for 
24-48 h. Control bacterial suspensions were run in parallel. Cell counting was performed 
per triplicate and SE was calculated. Viability was calculated as follows:  B=N/d were, 
B: number of bacteria; N: average number of colonies counted on three plates, and d: 
dilution factor. 
2.3.4 Analysis by flow cytometry (FC) 
After 60 min exposure, cell suspensions were diluted 1:10 in PBS, centrifuged (8000 
g for 20 min), washed, re-suspended in 2 mL of peptone-buffered water, Control samples 
without surfactant treatment were prepared in parallel. The staining protocols for FC 
experiments and FC analysis were reported earlier [24].  
2.3.5 Potassium leakage  
 The potassium concentration in the supernatant was measured with an Inductively 
Coupled Plasma Spectrometer (ICP_OES Perkin Elmer, model 3200Rl) using standard 
potassium ion solutions of 0-1ppm concentrations as the reference. Experiments were 
conducted in triplicate, and means and standard deviations were calculated[24].  
 
2.3.6. Observation by transmission electron microscopy (TEM) 
6 
 
Cell suspensions of E. coli O157:H7 CECT 4267 and L. monocytogenes ATCC 15313 
were exposed for 2 h with M80:20 (6.5 μM) and with C3(LA)2  (5 μM). Untreated cells 
were used as controls. 50 mL samples were taken, centrifuged (8000 x g for 20 min), and 
the bacterial pellets were rinsed with buffered peptone water (pH 7) three times. Samples 
were treated as reported [15, 24]. Ultrathin sections were cut with a Leica UCT ultra 
microtome and mounted on Formvar carbon-coated copper grids. Sections were 
poststained with 2% aqueous uranyl acetate and lead citrate and examined by a Tecnai 
Spirit electron microscope (FEI Company, Netherlands) at an acceleration voltage of 120 
kV and a computer program analySIS (Soft Imagine System, Switzerland).  
 
3. Results and discussion 
3.1 Surface Pressure-Area (π-A) Isotherms 
The monolayer compression isotherms (π-A) of pure LchAL1.1, C3(LA)2, and C6(LL)2, 
and C3(LA)2/LchAL1.1 and C6(LL)2/LchAL1.1 mixtures at proportions of 80:20 and 50:50 
are presented in Fig. 2. The shapes of the π-A isotherms of pure C3(LA)2 and C6(LL)2 
show a characteristic profile of surfactants with a relatively high solubility. At subphase 
pH 7.4, the evaluated compounds were in ionized form. C3(LA)2 has two positive charges 
situated in the guanidine groups (pKa=9), and while LchAL1.1 has one negative charge due 
to the aspartic acid residue (pKa=3.5). For C3(LA)2 it was observed that, under monolayer 
compression, the surface pressure (Fig 2a) increased slowly over large molecular areas 
(gaseous phase). At 125 Ǻ2/molecule, a liquid-expanded phase was observed. With 
further area compression, the monolayer collapsed and the surface pressure reached a 
value of 26 mN/m. The isotherm profile of C6(LL)2 was similar to that C3(LA)2. The 
isotherm shape of a pure LchAL1.1 monolayer implied that this monolayer behaves as an 
expanded monolayer at the interface, probably related to the big head groups of these 
molecules. When the monolayer was compressed, the liquid-expanded state appeared at 
225 Ǻ2/molecule, and then at 45 mN/m the monolayer collapsed.  
The monolayers corresponding to the C3(LA)2/LchAL1.1 mixtures showed a similar 
profile, independently of the proportions (M80:20, M50:50 in Fig. 2a). If the two 
monolayer components are miscible at the interface, the mixed monolayer should 
demonstrate intermediate isotherm behaviour between that of the corresponding pure 
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monolayer isotherms, and accordingly the curves of the C3(LA)2/LchAL1.1 mixtures lie 
between the curves of the pure components. This behaviour suggests the formation of a 
pseudo trialky surfactant with three charges, two cationic from the gemini (pK = 9) and 
one anionic from the LchAL1.1 (pK = 3.5), which partly neutralized each other. The 
formation of the catanionic systems is strongly synergistic. A clear effect was the surface 
pressure at monolayer collapse, which was higher than the value for C3(LA)2 alone and 
similar to that of LchAL1.1 (45 mN/m). The collapse occurred at values of areas lower than 
those in the isotherm of pure LchAL1.1. This indicates a higher surface density in the 
monolayer, probably due to the minor electrostatic repulsions. As stated, the interaction 
between a molecule of LchAL1.1 with one of a gemini surfactant could lead to the formation 
of a “pseudo-surfactant”, with a unique positive charge; one cationic charge of C3(LA)2 
is neutralized by the negative charge of LchAL1.1,resulting in a lower repulsion of 
molecules. The fact that the curve shape of the isotherm mixture C3(LA)2/LchAL1.1 did not 
change when varying the ratio of surfactants in the mixture (M80:20, M50:50) can be 
attributed to that, in both cases, the number of “pseudo-surfactant” molecules at the 
interface was the same.  
The π-A isotherms of the C6(LL)2/LchAL1.1 mixture (Fig. 2b) show a rather flat profile, 
which is characteristic of surfactants with high solubility and non-compressible spread 
monolayers. Taking into account the pKa of C6(LL)2 [20], pKa=7.8, it is expected that at 
pH 7.4, only 50% of C6(LL)2 molecules are ionized, and only 50% can interact with the 
molecules of LchAL1.1, and under compression conditions most of the molecules solubilise 




3.2 Size and zeta potential 
Surfactants form different types of aggregates, including vesicles. In order to 
determine what type of aggregate form the mixture of Gemini surfactants and LchAL1.1, 
two mixture proportions (80:20, 50:50) were studied, using dynamic light scattering 
measurements at 25ºC. To measure the aggregate size distribution, a polydispersity index 
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(PI), ranging from 0.0 for an entirely monodisperse sample to 1.0 for a polydisperse 
sample, is used. Results are shown in Table 1. 
In all cases, the scattering detected size ranges corresponding to medium and large 
vesicles. For C3(LA)2 dispersions, the aggregate sizes ranged from 30 to 800 nm, with a 
major intensity at 194 nm and with a polydispersity relatively high. At concentrations 
higher than the CMC, the gemini surfactant C3(LA)2 forms large globular aggregates [25] 
that can be twisted ribbons or helical aggregates depending on the concentration [26]. For 
LchAL1.1 dispersions, a bimodal size distribution with medium values of polydispersity of 
microstructures was observed, with one peak at around 100 nm and another at around 500 
nm. This result is fairly consistent with the results reported for surfactin dispersions [27], 
where a bimodal distribution was observed with an average size of 180 nm and 818 nm.  
In C3(LA)2/LchAL1.1 mixtures, the incorporation of C3(LA)2 (Table 1) into LchAL1.1 
dispersions clearly resulted in a loss of bimodality in LchAL1.1, favouring the formation of 
vesicles with an average size of about 200 nm and low polydispersity in both 80:20 (Fig. 
3a) and 50:50 proportions (Fig. 3b). This confirms the strong interaction of the 
C3(LA)2/LchAL1.1 mixtures, as explained previously in the isotherm analysis. Size of the 
C3(LA)2/LchAL1.1  aggregates also changed with time (data no shown), which is fairly 
consistent with information recently reported for surfactin vesicles [28]. For 
C6(LL)2/LchAL1.1 mixtures, the sizes of the aggregates were out of the detection range.  
The zeta-potential is obtained from the measurement of the electrophoretic mobility 
and is related to the electric charge of the vesicles. As a rule of thumb, it is considered 
that a system is electrostatically stable if the zeta-potential has an absolute value above 
20 mV. When the zeta potential is higher than 20 mV, colloidal solutions are stable, due 
to repulsive interactions between aggregates bearing the same charges. Due to the 
negative charge on the carboxyl group, the LchAL1.1 vesicles show a zeta-potential of -
37.6 mV (Table 1). The cationic surfactant C3(LA)2, with two positive charges on the 
guanidine groups, has a positive zeta potential of 49.7 mV. Notably, all the solutions had 
high zeta potential, which explains the stability of these dispersions. C3(LA)2 has two 
positive charges compared to a single negative charge of LchAL1.1, thus one LchAL1.1 
molecule can neutralize only one charge of C3(LA)2. The repulsion between aggregates 
is not strong enough to avoid coagulation and phase separation. Although both mixtures 
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were positively charged, their values were slightly different, i.e. the zeta potential for 
80:20 was 54 mV and 66 mV for 50:50. 
 
Antimicrobial activity of LchAL1.1, gemini surfactants and the gemini surfactant/ 
LchAL1.1 binary system.  
The combination of antimicrobial agents has generated great interest, since a 
synergistic activity may expand their range of action, prevent the emergence of resistance 
and reduce toxicity [4]. Catanionic mixtures of LchAL1.1/gemini surfactant were studied 
to assess if they had a synergistic antimicrobial effect [7]. It is well known that most of 
the Bacillus lipopeptides are effective antimicrobials, exhibiting MICs lower than 2 
μg/mL [29], However, LchAL1.1 inhibitory activity against a wide variety of 
microorganisms was weak (Table 2, Table 3).  
C6(LL)2 is a moderately effective antimicrobial agent against Gram-negative or Gram-
positive bacteria (Tabe 2). The MIC found ranged between 100-200 μM except in the 
case of S. epidermidis (50 μM). Despite the weak antimicrobial activity of LchAL1.1 (MIC 
>1 mM) and its low interaction with C6(LL)2 (see compression isotherms above), the 
antimicrobial activity against, M. luteus and B. subtilis was enhanced when mixed with 
LchAL1.1  in both proportions tested. 
Critical increase in antimicrobial activity was observed for C3(LA)2/LchAL1.1 (M80:20) 
against most of the bacteria assayed (Table 3). A significant reduction in MICs was 
observed against all Gram-negative bacteria studied Among the Gram-positive bacteria 
assayed (Table 3), a slight reduction in MIC was observed against S. aureus, B. subtilis, 
S. epidermis, K. rhizophila, and MRSA whereas relevant decrease was found in the case 
of L. monocytogenes and C. albicans. These results are consistent with the strong 
interaction of C3(LA)2 and LchAL1.1 observed in the isotherm.  
To assess the role of synergism in the antimicrobial activity of the formulations, the 
FIC was calculated following equation 1. A FIC≤ 0.5 indicated synergism, while values 
from 0.5 to 1 indicated no synergism, between 1 and 4 was defined as indifferent, and 
higher than 4 indicated antagonism [3, 35]. Accordingly, the activity of the binary system 
of C6(LL)2/LchAL1.1 M80:20 (Table 2), except against B. subtilis and K. rhizophila, clearly 
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showed no synergism, which is consistent with the low interaction between the two 
components indicated  by the isotherm.  
The C3(LA)2/LchAL1.1 M80:20 clearly acted synergistically against most of the 
microorganisms assayed (Table 3) showing stronger synergy than C6LL2 binary system 
(t= 3.1652, 11 d.o.f. with p<<0.05) [23] No synergism was observed against the Gram-
positive bacteria assayed (FIC >0.5), with the exception of B. subtilis and K. rhizophila. 
The high interaction of both compounds detected by isotherms and their ability to form 
aggregates could be responsible for the antimicrobial activity of this mixture against 
Gram-negative bacteria.  
It has been reported that, in general, Gemini surfactants structures show higher activity 
than their single chain analogues due to the enhanced intermolecular hydrophobic 
interactions [38]. The different synergism obtained for C3(LA)2 and C6(LL)2 can be 
attributed to the different pKa values of these surfactants. Such synergistic interactions 
allow the use of lower dosages and can also extend the range of actuation. 
Novel formulations containing antimicrobial peptides (AMPs) and cationic lipids have 
been proposed in order to improve the therapeutic index of AMPs and their 
bioavailability. In general this aproach consist on the encapsulation of the AMPs on 
liposomes prepared with lipids. This strategies increases fusion between liposomal AMPs 
and the bacterium membrane thereby increasing the antibacterial activity [30]. 
The scarce information in the literature on the antimicrobial behaviour of binary 
systems involving biosurfactants is mainly limited to their physico-chemical properties 
[31, 32], demonstrating the synergic effect between rhamnolipids and nisin, an 
antimicrobial peptide, which enhanced the effectiveness against L. monocytogenes [33]. 
Another study has demonstrated that lipopeptide V9T14, a biosurfactant produced by 
Bacillus, in association with antibiotics leads to a synergistic increase in biofilm 
elimination efficacy, and in some combinations leads to total eradication of E. coli 
CFT073 biofilm [3]. A synergistic action of sophorolipids and tetracycline has been 
described, with sophorolipids enhancing the drug action by facilitating the entry across 
the cell membrane, thus achieving the requisite intracellular antibiotic concentration at a 
low dosage [34]. These and the findings presented here provide new data on potentially 
useful interactions against pathogens. Importantly, the addition of LchAL1.1 to C3(LA)2 
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improved the antimicrobial action against Gram-negative bacteria, which are responsible 
for a large proportion of antibiotic-resistant bacterial diseases.  
 
3.4. Effect of the C3(LA)2/LchAL1.1 (80:20) mixture against E. coli O157: H7 and L. 
monocytogenes culture viability. 
In order to analyse the antimicrobial mechanism of the C3(LA)2/LchAL1.1 (M80:20), 
two microorganisms particularly problematic for the food industry, E. coli O157:H7 and 
L monocytogenes, were chosen. Shiga toxin-producing E. coli O157:H7 causes 
gastrointestinal infections, such as haemorrhagic colitis, and haemolytic uremic 
syndrome, which is life-endangering [35]. L. monocytogenes ATCC 15313 grows in 
many animal food products, affecting food safety, can cause listeriosis and may be 
involved in meningitis, encephalitis, septicemia and abortions  [36]. The time course of 
the antimicrobial effect of the C3(LA)2/LchAL1.1 (M80:20) was followed by a viable cell 
count. When E. coli O157:H7 cells were treated at the MIC concentration (6.25 µM), an 
effective reduction of viability (87.5%) was found after 30 minutes of treatment reaching 
a maximum (99.99%) after 120 min  (Fig. 3, Table 4).  When treated with each of the 
components of the binary system separately at the equivalent concentration, the geminal 
arginine surfactant C3(LA)2 (5 µM) produced a decrease of viability of 53.4% after 30 
minutes of treatment. This effect was time dependent, increasing to 61.0% at 60 min 
(Table 3a) being 76.1% after 120 minutes. As expected, no antimicrobial effect was found 
for LchAL1.1 (1.5 µM). These results are consistent with the antimicrobial synergy (FIC 
=0.04) found between both compounds at the ratio M80:20 (Table 3). The binary system 
clearly produces a higher loss of viability in a shorter treatment time. 
A different effect was observed in the case of L. monocytogenes, when the bacterial 
population was treated with the binary system at MIC concentration (6.25 µM). As 
expected, the C3(LA)2/LchAL1.1 (M80:20) exhibited higher antimicrobial activity than the 
individual components; a reduction of 44.1% viability was found after 30 min of 
treatment, which slowly increased to 99.8%  after 120 min of contact (Table 3b, Table 4). 
When applied separately at the concentration of the mixture, the maximum effect of 
C3(LA)2 was 26.5% at 30 min of contact increasing to 59.0% after 60 minutes (Table b)  
reaching 84.8% reduction after 120 min of contact. No effect was observed with 
lychenysin. These results are accordance with the structural characteristics of the assayed 
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bacteria,  the effects of the treatment being higher and faster in E. coli (Gram-negative) 
than L. monocytogenes (Gram-positive). 
 
3.5. Flow cytometric (FC) analysis of the population of E. coli O157:H7 and L. 
monocytogenes after treatment with the C3(LA)2/LchAL1.1 (80:20) mixture.  
The cell damage produced by the binary system M80:20 and the controls, C3(LA)2 and 
LchAL1.1, is presented in Table 4. When bacteria treated with any of the compounds 
assayed, the binary system or the individual components, three subpopulations of cells 
were observed: i) an unstained population, labelled in grey, corresponding to intact cells 
(D3); ii) a second subpopulation labelled in green (BOX-stained), corresponding to 
depolarized cells (D4); and iii) a third subpopulation of cells, labelled in red, which 
retained PI, indicating permeabilized cells, i.e. severely damaged cells (D1, D2).  
E. coli O157:H7 cells were considerably disturbed, as M80:20 had a significant effect 
on membrane potential after 60 minutes of treatment at the MIC concentration (6.25 μM) 
compared with the negative control. 62.4 % of the population had the membrane 
depolarized (BOX-stained cells), which suggests a blockage in the respiratory chain as 
shown in Table 4. In contrast, exposure to pure C3(LA)2  (Fig. 4) or LchAL1.1 had no notable 
effect on membrane potential: the proportion of BOX-stained cells was 3.8 and 1.3 %, 
respectively. The most damaged cells, those with a permeabilized membrane (PI stained 
cells), reached 46.8 % after 60 min of contact (Table 4). Exposure to pure C3(LA)2 and 
LchAL1.1 had a negligible effect on membrane permeability, the proportion of PI-stained 
cells being only 1.1% (Figure 4) and 1.6 % (Table 4). The strongest effect on cell 
reduction viability (100%) was caused by the M20:80 mixture after 60 min of contact, 
whereas with LchAL1.1 only 1% loss of viability was observed (Table 4). However, 
divergences were seen with pure C3(LA)2: after 60 min of contact, the viability reduction 
was approximately 61 %, while only 4.9 % of affected cells were detected by FC (Table 
4). This considerable disparity suggests that C3(LA)2 at an equivalent concentration to the 
mixture induced a loss in viability by a mechanism different to that evaluated by FC. 
The response of the L. monocytogenes population to treatment with C3(LA)2,  LchAL1.1 
and M20:80 was also analysed (Table 4, Fig. 5). At the MIC (6.5 μM), M20:80 
depolarized 38.4 % of cells. In contrast, the effect of C3(LA)2 and LchAL1.1 on the 
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membrane potential was low, being 8.8% and 4.3 % respectively. The maximum effect 
of M80:20 on membrane permeability was observed after 60 min of contact, when 64.4% 
of cells were BOX-stained and  PI-stained. Exposure to C3(LA)2 and LchAL1.1 had little 
effect on membrane permeability; the proportion of PI-stained cells was 8.2% and 14.4 
% (Table 4) respectively. It is noteworthy that although only 17% of cells were visibly 
affected by C3(LA)2, the reduction of viability was 60% (Table 4), suggesting an 
unspecific cell damaging effect associated with metabolic activity but not detected by FC. 
When compared with the results against E. coli O157:H7, the inhibiting effect of M80:20 
was clearly lower against Gram-positive bacteria. The plate counts for both bacteria 
confirm that the antimicrobial-led alterations observed by FC, i.e., loss of membrane 
functionality and inhibition of respiratory activity, can result in cell death. 
The proposed primary mode of antimicrobial action of lipopeptides is pore formation 
in membranes, leading to an imbalance of transmembrane ion flux and cell death [37, 38]. 
Recently, lichenysin interaction with a DPPC-model membrane was demonstrated, 
indicating that lichenysin penetrates inside the membrane [39]. Despite the low 
percentage of affected cells detected by bacterial count and by flow cytometry the present 
work assess the synergistic role of lichenysin, at low concentration, in the antimicrobial 
activity of the binary system with C3(LA)2 .  
 
3.6. Potassium ion leakage from E. coli O157:H7 and L. monocytogenes cultures 
To determine changes in cell membrane permeability, K+ leakage from E. coli 
O157:H7 and L. monocytogenes was examined during exposure to the M80:20,  
lichenysin and C3(LA)2. This approach is used to study antimicrobial effect on membrane 
integrity [2, 24, 40]. K+ is the most abundant intracellular cation in all living organisms, 
including bacteria, and is essential for many cellular functions. 
E. coli O157:H7 cells showed some leakage of intracellular K+ in response to M80:20 
and C3(LA)2 but no leakage was detected with lichenysin (Fig. 6a). The amount of 
extracellular K+ after 15 min of contact was 0.26 and 0.34 ppm, respectively, which was 
lower than in the thermally treated population (0.81 ppm). In the case of L. 
monocytogenes, intracellular K+ leakage after exposure to M80:20 and C3(LA)2 is shown 
in Figure 6b. Exposure to M80:20 after 15 min produced a K+ concentration of 0.1 ppm 
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in the supernatant, whereas with C3(LA)2 it was 0.12 ppm, less than with the heat 
treatment (0.60 ppm).  These results demonstrate that binary system induced leakage of 
intracellular K+ from E. coli O157:H7 cells and to a lesser extent in L. monocytogenes. 
Dissipation of the K+ gradient across the cell membrane is a consequence of membrane 
damage and breakdown of the permeability barrier. K+ leakage has been reported as 
higher in Salmonella Thiphymurium than in S. aureus treated with an arginine-derived 
surfactant [40]. Our results suggest that the biocide mechanism of action affects the 
cellular membrane with subsequent loss of intracellular K+, although the binary system 
did not increase the K+ leakage.  
 
3.7. Transmission Electron Microscopy (TEM) of E. coli O157:H7 and L. 
monocytogenes 
The effect on bacterial ultrastructure was assessed using TEM. Electron micrographs 
of E. coli O157:H7, used as a control, show a dense and compactly structured membrane. 
After exposure to 5 μM C3(LA)2, part of the E. coli O157:H7 population showed multiple 
alterations in the cytoplasm (Fig. 7a). Intracytoplasmic white regions and collapse of the 
cytoplasm were observed, although it should be stressed that membrane integrity was 
apparently maintained. The collapse of the cytoplasm could explain the reduction of 
viability without evidence of physical disintegration of the membrane (Table 4). In 
contrast, M80:20 caused major structural changes in E. coli O157:H7 cells (Fig. 7b). Due 
to the breakdown of the cytoplasmic membrane, leakage of the cytoplasm was observed 
outside the cells. The mixture caused a far greater effect than C3(LA)2 alone, not only in 
terms of changes in the cytoplasm, but in the degree of membrane damage. 
Electron micrographs of L. monocytogenes, used as a control, depict a dense and 
compact membrane structure, as well as a thick peptidoglycan. The surfactant C3(LA)2 
caused the formation of clearly visible mesosomes (Fig.8a),  but the cell structure and 
form was not affected. Nevertheless, 69.3% reduction in viability was found (Table 4), 
suggesting that the changes produced in L. monocytogenes by M80:20 were critical. 
Figure 8b shows an alteration in cell morphology, possibly related to the loss of 
peptidoglycan rigidity, but only a low amount of cytoplasmic material was leaked. Thus, 
more cellular damage was caused by the C3(LA)2/LchAL1.1 (M80:20) than by C3(LA)2 
alone in both strains; this observation is consistent with the results obtained by FC and 
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plate count. LchAL1.1 did not affect the integrity of the cell envelopes in E. coli O157:H7 
and L. monocytogenes or the cell viability within the concentrations tested. 
Similar results were found with the bis(Na-caproyl-L-arginine)-1,3-propanediamine 
dihydrochloride surfactant (C3(CA)2), which induces loss of membrane integrity in E. coli 
ATCC 10536, while in S. aureus ATCC 91444 lysosome formation and cytoplasm 
precipitation zones were observed [41] .Treatment with C3(LA)2 alone did not produce 
critical structural damage in the cell envelopes of E. coli O157:H7 in contrast with those 
reported with C6(LL)2 which produced breakage of the membrane leading to a  massive 
lysis of the culture[19]. The ultrastructural changes observed in the case of L. 
monocytogenes were found also in S. aureus when treated with C6(LL)2 or other 
aminoacid-derived surfactants,  changes in the morphology of the cells and mesosomes 
formations [19]  
The trend for using compatible agents such as amino acid-derived surfactants in 
pharmaceutical or food industry formulations [42] may be reinforced by the use of co-
surfactants to enhance antimicrobial properties. LchAL1.1 improved the antimicrobial 
activity of the gemini arginine surfactant C3(LA)2,  mainly against Gram-negative 
bacteria. This suggests a potential application for this lipopeptide as a surfactant and 
antimicrobial ingredient in formulations. Indeed, the antimicrobial activity of essential 
oils is increased with emulsification mediated by rhamnolipids [43].  
The results indicate that the binary system (M80:20) caused a loss of cell viability and 
disruption of the cell wall. The antimicrobial synergism between C3(LA)2 and LchAL1, 
may be explained considering the strong interaction previously observed, where 
suggested a “pseudo-surfactant” formation. This “pseudo-surfactant” could produce a 
stronger hydrophobic interaction with lipid bilayer, besides the stronger electrostatic 
interaction, given by guanidine group, unique positively charged group, present in the 
mixture and acting as similar to cationic surfactant. 
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Figure 1. Structures (A) LchAL1.1 and (B)  C3(LA)2, C6(LL)2 compounds. 
 
Figure 2. π-A Compression isotherms. a) pure C3(LA)2 surfactants, LchAL1.1 and binary 
mixtures (M 80:20 and M 50/50) of C3(LA)2/LchAL1.1. b) pure C6(LL)2 surfactants, 
LchAL1.1 and binary mixtures (M 80:20 and M 50/50) of C6(LL)2/LchAL1.1. The subphase 
was Tris (pH = 7.4).  
  
Figure 3. Reduction of cell viability (cfu/ml) versus time: (a) E. coli O157:H7 (B) L. 
monocytogenes. C3(LA)2 (5 µM) (□); C3(LA)2/ LchAL1.1 (80:20) MIC (Δ) and LchAL1.1 
(1.25 µM) (◊). The data correspond to the average of three independent experiments 
± SE (error bars). 
 
Figure 4. Dual parameter of E. coli O157:H7 stained cells (BOX and PI) caused by 
exposure to C3(LA)2 /LchAL1.1 (80:20) and C3(LA)2 (a) cells treated with C3(LA)2 at the 
concentration in the mixture (5 µM) (b) cells treated with C3(LA)2 /LchAL1.1 (M80:20) at 
MIC concentration ( 6.25µM). In all cases, time of contact was 1 h. 
 
Figure 5. Dual parameter of L. monocytogenes stained cells (BOX and PI) caused by 
exposure to C3(LA)2 /LchAL1.1 (80:20), C3(LA)2 and LchAL1.1. (a) cells treated with 
C3(LA)2 at the concentration in the mixture (5 µM),  (b) cells treated with C3(LA)2 




Figura 6. Potassium leakage of the cell suspension of (a) E. coli O157:H7 and (b) L. 
monocytogenes exposed to C3(LA)2 5 µM (●);C3(LA)2/LchAL1.1 (80:20) MIC(■); 
exposure to 70ºC (▲) acted as positive control. LchAL1.1 doesn´t cause potassium leakage.  
Figure 7. Effect on membrane ultrastructure of E. coli O157:H7 caused by exposure to 
C3(LA)2/ LchAL1.1 (M80:20) at CMI concentration (6.5 μM) and C3(LA) at the proportion 
in the mixture (5 μM), shown by transmission electron microscopy. a) C3(LA)2 5 µM, 
(50X) and b)  C3(LA)2/LchAL1.1 (M80:20) (50X). In all cases, time of contact was 120 
min.  
 
Figure 8. Effect on membrane ultrastructure of L. monocytogenes caused by exposure to 
C3(LA)2/ LchAL1.1 (M80:20) and C3(LA)2 at the corresponding MIC concentration, shown 
by transmission electron microscopy. a) C3(LA)2 5 µM, (50X) and b)  C3(LA)2/LchAL1.1  
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